Latest Asx Companies News

Tissue Repair Limited has responded to an ASX price query following a sharp rise in its share price and trading volume, denying any undisclosed information and confirming compliance with listing rules.

Activeport Group Ltd has revised the timetable for its pro-rata bonus issue of unquoted options, outlining key dates and eligible shareholders across multiple countries.

Sagalio Energy Limited’s shares have been suspended from ASX trading due to compliance concerns, leaving investors in the dark about the company’s next steps.

Vectus Biosystems has responded to an ASX price query following a dramatic spike in its share price and trading volume, denying any undisclosed information and confirming compliance with ASX rules.

Anteris Technologies has updated the timetable for its Australian capital raising, delaying settlement to November 4 and the start of trading for new securities to November 5. The company also highlights restrictions on U.S. investors acquiring its CDIs.

Equity Story Group has raised $650,000 through a strategic convertible loan led by new Non-Executive Chair Alex Brinkmeyer, signaling a pivot into property funds management. The company also announced significant board changes, including the appointment of David Nolan as Managing Director.

Barton Gold Holdings has been added to the S&P Dow Jones ASX All Ordinaries Index, marking its rise among Australia's top 500 companies. The company is accelerating development of its South Australian gold projects, targeting significant production milestones by 2026.

The ASX has suspended trading in six companies starting 1 September 2025 due to late lodgement of mandatory periodic reports. The suspension may be lifted quickly if reports are filed promptly.

Invion Limited has disclosed that the US FDA granted Orphan Drug Designation for its lead cancer drug candidate INV043, explaining recent unusual trading activity in its shares. The company confirmed it was unaware of the FDA decision prior to its public release and has now complied with continuous disclosure rules.

Star Minerals Limited addresses a sharp rise in its share price and trading volume, attributing the movement to pending assay results from recent drilling activities. The company confirms compliance with ASX disclosure rules while preparing to release interpreted data.

Miramar Resources has extended its Share Purchase Plan closing date to 27 August 2025, giving shareholders more time to invest at a 20% discount as the company awaits critical exploration results.

Rhythm Biosciences has responded to an ASX price query following a sudden surge in its share price and trading volume, confirming no undisclosed information is driving the activity.